Adam Laponis (Chief Financial Officer) sold ~$1.52M of Twist Bioscience
Automatic saleLoading…
Insider tradesView the official recordSEC Form 144 — Notice of Proposed Sale of Securities
Planned sale
Officer filed to sell about $1.8M of TWST stock
Planned for Oct 2, 2026 · Notice filed Oct 2, 2026
- ~$1.8M
- planned to sell · 9,514 shares, around Oct 2, 2026
Why it stands out
A Twist Bioscience officer told the SEC about a plan to sell $1.8M of Twist Bioscience shares around Oct 2, 2026. The filing says the shares were acquired as compensation. That is a tiny part of all Twist Bioscience shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Planned sale date
- Oct 2, 2026
- Reporting period
- Not applicable
- Notice filed with the SEC
- Oct 2, 2026
OfficerPlanned saleShares from pay
Context
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001959173-26-007244
- Filed / recorded
- Oct 3, 2026, 12:41 AM UTC